Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02437851 · ClinicalTrials.gov registry record · Phase 2
Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
A Phase 2 study of HIV Infection and Anal Squamous Cell Carcinoma, sponsored by AIDS Malignancy Consortium.
- Active
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
- 5
- Study locations
NCT02437851: Active Phase 2 study of HIV Infection and Anal Squamous Cell Carcinoma, sponsored by AIDS Malignancy Consortium.
NCT02437851 is a Phase 2 study of HIV Infection and Anal Squamous Cell Carcinoma that is active but no longer recruiting, run by AIDS Malignancy Consortium. The registered enrollment target is 16 participants, below the 243-participant average among 73 other HIV Infection trials with a reported enrollment target (93% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02437851, a Phase 2 study of HIV Infection and Anal Squamous Cell Carcinoma, is active but no longer recruiting, sponsored by AIDS Malignancy Consortium.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
- 5
- Study locations
Study Summary
This phase II trial studies surgery in treating patients with anal canal or perianal cancer that is small and has not spread deeply into the tissues and human immunodeficiency virus (HIV) infection. Local surgery may be a safer treatment with fewer side effects than bigger surgery or radiation and chemotherapy.
Primary Outcome
Treatment failure is specifically defined as the occurrence of distant or any nodal metastases or recurrence of cancer that no longer meets the definition of SISCCA and that cannot be excised with a clear margin or preservation of sphincter function and requires CMT, or those who develop SISCCA recurrence but elect to undergo CMT rather than repeat excision in patients originally treated with excision of anal canal and perianal SISCCA.
Conditions Studied
Interventions
- PROCEDURE Therapeutic Conventional Surgery
Study Locations (5)
New York
- Laser Surgery Care - New York
- Montefiore Medical Center - The Bronx
California
- University of California, San Francisco - San Francisco
Georgia
- Grady Health System - Atlanta
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-04 |
| Est. Completion | 2026-03-21 |
| Phase | Phase 2 |
What the registry record for NCT02437851 still lists
NCT02437851 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 243-participant average among 73 other HIV Infection trials with a reported enrollment target (93% lower).
The record links to 4 conditions, with HIV Infection appearing as the primary indexed condition, and to 1 intervention - of which Therapeutic Conventional Surgery is the first listed.
NCT02437851 lists 5 locations in 4 states (New York, California, Georgia).
Frequently Asked Questions
What is clinical trial NCT02437851 about?
NCT02437851 is a clinical study titled "Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection". This phase II trial studies surgery in treating patients with anal canal or perianal cancer that is small and has not spread deeply into the tissues and human immunodeficiency virus (HIV) infection. Local surgery may be a safer treatment with fewer side effects than bigger surgery or radiation and c...
What is the current status of trial NCT02437851?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2015-04. Estimated completion is 2026-03-21.
What conditions does trial NCT02437851 study?
This clinical trial studies the following conditions: HIV Infection, Anal Squamous Cell Carcinoma, Stage 0 Anal Canal Cancer, Stage I Anal Canal Cancer.
What interventions are being tested in trial NCT02437851?
The interventions under investigation include: Therapeutic Conventional Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02437851?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02437851 being conducted?
This trial has 5 study locations across California, Georgia, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02437851's enrollment target sits among peer trials
16 67th of 73 higher than 7 of 73 other HIV Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
RECRUITING · Phase 2
-
A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection
ACTIVE NOT RECRUITING · Phase 2
-
The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART
COMPLETED · Phase 2
-
Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women
COMPLETED · Phase 2
-
Thalidomide to Treat Oral Lesions in HIV-Infected Patients
COMPLETED · Phase 2
-
A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia